...
首页> 外文期刊>The journal for nurse practitioners: JNP >Erratum to Contemporary Management of Atrial Fibrillation [The Journal for Nurse Practitioners - JNP, (2013) 645]
【24h】

Erratum to Contemporary Management of Atrial Fibrillation [The Journal for Nurse Practitioners - JNP, (2013) 645]

机译:对当代房颤管理的勘误表[The Journal of Nurse Practitioners-JNP,(2013)645]

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The article "Contemporary Management of Atrial Fibrillation," written by Leslie L. Davis, Guest Editor of the November/December 2013 issue, contained an error. On page 645, this sentence should have read, "Likewise, patients who are on a newer antithrombotic agent (dabigatran [Pradaxa~R], rivaroxaban [Xarelto~R], and apixaban [Eliquis~R]) should also start taking these medications for at least 30 days before the attempt to restore sinus rhythm by chemical or DCCV."
机译:2013年11月/ 12月号的客座编辑莱斯利·戴维斯(Leslie L. Davis)撰写的文章“房颤的当代管理”包含一个错误。在第645页上,该句应为:“同样,正在使用新型抗血栓药(达比加群[Pradaxa〜R],利伐沙班[Xarelto〜R]和阿哌沙班[Eliquis〜R])的患者也应开始服用这些药物尝试通过化学或DCCV恢复窦性心律之前至少持续30天。”

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号